MT2A and urinary bladder carcinoma: Moreover, a study indicated that MT2A has tumor-suppressive activity through inhibiting nuclear transcription factor κB (NF-κB) signalling in gastric cancer patients [11]; however, the functions and expressions of MT2A in bladder cancer have not been thoroughly scrutinized.